Security Snapshot

SEATTLE GENETICS INC - COM (SGEN) Institutional Ownership

CUSIP: 812578102

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SGEN - SEATTLE GENETICS INC - COM is tracked under CUSIP 812578102.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 3 to 0 between Q3 2023 and Q4 2023.
  • SEC-reported value moved from $5,286,595 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

812578102

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
40
Latest
n/a
Rows shown
1-25 of 40
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$5,286,595 0
2023 Q3 24,919 $5,286,595 -$3,059,634 $212.15 3
2023 Q2 41,477 $7,982,969 +$3,024,430 $192.46 4
2023 Q1 25,764 $5,216,437 -$5,677,700 $202.47 2
2022 Q4 69,945 $8,988,631 -$4,744,846 $128.51 4
2022 Q3 106,867 $14,622,000 -$3,543,163 $136.83 3
2022 Q2 129,755 $22,959,000 -$7,548,748 $176.95 3
2022 Q1 172,563 $24,839,000 +$4,243,764 $144.02 4
2021 Q4 142,904 $22,069,006 -$6,214,401 $154.55 5
2021 Q3 179,050 $30,434,000 -$3,795,814 $169.81 9
2021 Q2 197,942 $31,250,000 +$4,796,974 $157.86 6
2021 Q1 167,769 $23,296,000 -$84,897,861 $138.87 8
2020 Q4 655,594 $114,820,000 -$20,749,012,541 $175.14 17
2020 Q3 107,006,728 $20,903,721,082 -$9,082,051,270 $195.69 388
2020 Q2 160,907,362 $27,326,078,670 -$558,523,455 $169.92 484
2020 Q1 164,748,250 $19,004,617,171 +$177,933,009 $115.38 380
2019 Q4 163,205,704 $18,645,276,325 -$337,808,298 $114.26 388
2019 Q3 165,320,231 $14,110,723,053 +$497,079,069 $85.40 317
2019 Q2 160,955,072 $11,136,717,667 -$19,298,142 $69.21 317
2019 Q1 161,967,217 $11,861,268,308 -$114,684,352 $73.24 335
2018 Q4 163,694,210 $9,274,001,669 +$7,094,549 $56.66 294
2018 Q3 163,166,313 $12,583,486,736 -$126,922,552 $77.12 320
2018 Q2 165,150,062 $10,963,789,253 -$317,143 $66.39 288
2018 Q1 165,565,585 $8,665,636,727 +$990,377,878 $52.34 279
2017 Q4 147,155,743 $7,872,607,446 +$190,208,976 $53.50 291
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .